You are 80 away from free shipping.
Receive a free OUMERE travel set with this order. Add $600 worth of OUMERE to your cart, add a travel set and enter code TRAVELSET at checkout to receive your OUMERE gift.
There are no other products available for purchase
Products
New FDA Warning for Microneedling: An OUMERE Scientific and Regulatory Analysis
By Wendy Ouriel
UMERE Laboratory Exhibition
A report from the UMERE Laboratory that examines regulatory risk, biological mechanisms of injury, and why “controlled injury” is incompatible with skin health.
Posted: Author: Wendy Ouriel Regulatory • Biology • Safety
Executive Summary
In October 2025, the The US Food and Drug Administration issued a Safety Communication warning of serious complications associated with radio frequency (RF) microneedling.including burns, fat loss, nerve injury and disfigurement.
OUMERE does not support microneedling or any intervention based on deliberate tissue damage to simulate regeneration. Biology shows that repetitive trauma leads to fibrosis and degrada-not Renaissance.
“Injury is pathology, not progress.” — UMERE Laboratory
RF microneedling is a medical procedure with documented risks. The FDA’s warning underscores the need for regulatory literacy and rejection of “injury as cure” narratives.
1. Overview of regulations
The FDA classifies microneedling devices as Class II medical devices (21 CFR 878.4430) due to hazards inherent in penetration of living tissue. Only limited indications are cleared and these gaps are not blanket approvals of safety in all body areas, depths or energy settings.
FDA Safety Notice (October 2025): reports of thermal burns, fat necrosis, scarring, disfigurement, and nerve injury associated with some uses of radiofrequency microacupuncture. warnings for untrained operators, off-label use, and unapproved devices in the home.
2. The biological fallacy of “controlled injury”
2.1 Injury vs. Regeneration
Microneedling initiates the wound healing cascade (hemostasis → inflammation → proliferation → remodeling). This path favors fibrotic repair (type III “scar” collagen) over the organized Type I collagen that is characteristic of youthful, uninjured skin.
Introduces thermal enhancement with RF coagulation necrosis and possibilities fat depletionwhich can manifest as thinning or hollowing—sometimes misconstrued as “tightness.”
2.2 The clinical illusion
Transient swelling and inflammation can momentarily smooth the appearance of the surface. As the inflammation subsides, the underlying uterus may show signs of scarring accelerated disorganization and agingaccording to adverse outcomes documented by the FDA.
3. Regulatory & Ethical Implications
The marketing language – “collagen induction”, “microchannels”, “controlled injury” – has medicalized aesthetic trauma. Devices that penetrate living skin are not lifestyle tools. it is medical devices which requires clinical governance and sober risk disclosure.
- Evidence gap: No independent, long-term human data show that chronic microneedling improves skin biological age or collagen architecture.
- Danger at home: Consumer tools often avoid oversight while promising “professional results,” creating a misalignment between claims and safety validation.
4. Scientific Position UMERE
OUMERE rejects the assumption that inflammation or injury is regenerative. Our lab methodology focuses on non-traumatic rehabilitation— supports barrier integrity, microbiome balance and oxidative balance without causing damage.
Basic Principles
- No injury is regenerative. Each “controlled wound” accelerates cellular aging and fibrosis.
- Inflammation ≠ improvement. Redness signals cytokine alarm, not renewal.
- Preservation versus challenge. Youthful architecture is maintained by protecting the skin’s intrinsic systems.
5. The Path Forward
The FDA’s stance is a turning point away from “collagen induction” devices and toward evidence-based conservation biology. OUMERE’s formulations are designed to respect the skin’s living systems rather than bypassing them with trauma.
Editor’s Workshop Note
Biological Principle: Each microneedle puncture triggers proinflammatory cytokines (eg, IL-6, TNF-α) and fibroblast responses typical of emergency repair, driving fibrosis. OUMERE’s research focus is to prevent unnecessary activation of this cascade by keeping the skin in uninjured, regenerative steady state.
Further Reading & Research
Clinical & Regulatory Framework
See the FDA’s 2025 Safety Notice for RF Microneedling and microneedling regulatory guidance documents for the latest federal perspective.
Medical disclaimer: This report is for scientific and educational purposes only and does not constitute medical advice. Procedures involving penetration of live skin should be evaluated by licensed medical professionals in accordance with applicable regulations.
Link copied to clipboard
{“themeColor”:”#000000″,”iconColor”:”#000000″,”showLogo”:true,”topBottomPosition”:10,”rightLeftPosition”:10,”iconSize”:”extra-small”,”iconCustomSize”:64″”middle””:
